In this issue:
JAK 1 inhibitor in moderate-tosevere psoriasis
Psychological stress and psoriasis
Matching-adjusted indirect comparison of ixekizumab vs secukinumab
Certolizumab pegol for chronic plaque psoriasis
Bimekizumab for psoriasis
Narrowband UVB clinical and dermoscopic response indicators
A new tool for PsA screening by dermatologists
Psoriasis and cardiovascular disease risk factors
Etanercept in children with plaque psoriasis
Please login below to download this issue (PDF)